XENE icon

Xenon Pharmaceuticals

174 hedge funds and large institutions have $2.36B invested in Xenon Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
+12
Holders Change %
+7.41%
% of All Funds
2.74%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
33
Increased
57
Reduced
56
Closed
20
Calls
$5.17M
Puts
$3.07M
Net Calls
+$2.1M
Net Calls Change
-$8.21M
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
51
Morgan Stanley
New York
$7.91M -$1.44M -37,445 -15%
Bank of Montreal
52
Bank of Montreal
Ontario, Canada
$7.83M +$7.83M +191,011 New
Axa
53
Axa
France
$7.43M +$102K +2,655 +1%
Jennison Associates
54
Jennison Associates
New York
$7.25M +$7.25M +188,391 New
GTC
55
Ghost Tree Capital
New York
$7.12M -$578K -15,000 -8%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$7.11M +$6.35M +164,952 +838%
SSA
57
Schonfeld Strategic Advisors
New York
$6.94M -$4.62M -119,976 -40%
Franklin Resources
58
Franklin Resources
California
$6.65M +$116 +3 +0%
EP
59
Eversept Partners
New York
$6.6M -$1.23M -31,894 -16%
PI
60
Putnam Investments
Massachusetts
$6.36M +$455K +11,807 +8%
Ensign Peak Advisors
61
Ensign Peak Advisors
Utah
$6.33M
Bank of America
62
Bank of America
North Carolina
$6.14M +$973K +25,265 +19%
Russell Investments Group
63
Russell Investments Group
United Kingdom
$5.79M +$2.51M +65,098 +76%
Point72 Asset Management
64
Point72 Asset Management
Connecticut
$5.71M -$13.7M -356,416 -71%
AG
65
Algert Global
California
$5.58M +$4.1M +106,470 +277%
IC
66
Ikarian Capital
Texas
$5.22M -$963K -25,000 -16%
NFGH
67
Nan Fung Group Holdings
Hong Kong
$4.4M
DnB Asset Management
68
DnB Asset Management
Norway
$4.34M +$530K +13,770 +14%
Swiss National Bank
69
Swiss National Bank
Switzerland
$4.23M +$327K +8,500 +8%
PHS
70
PFM Health Sciences
California
$3.86M
BAMCO Inc
71
BAMCO Inc
New York
$3.85M +$1.04M +27,100 +37%
SCM
72
Silverarc Capital Management
Massachusetts
$3.84M +$120K +3,113 +3%
D.E. Shaw & Co
73
D.E. Shaw & Co
New York
$3.8M -$4.16M -107,927 -52%
CM
74
Castleark Management
Illinois
$3.64M +$645K +16,750 +22%
Walleye Capital
75
Walleye Capital
New York
$3.45M -$602K -15,628 -15%